August 27, 2015
Ono Pharmaceutical said on August 26 that it has filed a new drug application for the proteasome inhibitor carfilzomib for Injection (development code: ONO-7057) for the treatment of relapsed or refractory multiple myeloma. The drug has been granted an orphan...read more